ESR1 and breast cancer: A characteristic of premalignant hyperplasia and breast cancer is an increase in the percentage of proliferating ER+/PR+ cells, where hormone-regulated proliferation is primarily autocrine-mediated and directly correlates with breast cancer risk (14, 18-20, 44).